Interactions on record — worth a quick check against your medications. Based on 3 of 7 ingredients. Check your meds →
Dietary supplement

Pro-X10 Ingredients & Drug Interactions

by BioTrust

Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Pro-X10 is a dietary supplement by BioTrust with 7 active ingredients. Its ingredients are commonly taken for digestive health and balance, diarrhea (including antibiotic-related), vaginal yeast and bacterial infections.Based on those ingredients, 182 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Lactobacillus acidophilus, Bifidobacterium breve, DE111 Bacillus subtilis. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Pro-X10 by BioTrust

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 1 of its 7 active ingredients.
  • “Microencapsulated Probiotic Blend” is a proprietary blend — the label doesn't break down how much of each component you get.

Pro-X10 is a 7-ingredient probiotic capsule centered on live, active cultures—beneficial bacteria meant to support your gut health. The three main strains we have interaction data for are Lactobacillus acidophilus, Bifidobacterium breve, and Bacillus subtilis.

Three other probiotic ingredients are also included, though we hold no interaction information for them. The product also contains inactive ingredients: gelatin, rice dextrin, medium chain triglyceride, and filtered water.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Moderate

Some clinical evidence supports this product's ingredients for its stated purpose, but it isn't conclusive.

Why this rating?
  • The label markets this product for: Daily GI health and bowel regularity.
  • We looked for evidence on: Antibiotic-associated diarrhea, Colic, Clostridioides difficile infection, Constipation, Diarrhea, Dyspepsia — and 4 related terms.
  • The strongest evidence on file: Lactobacillus Acidophilus is rated "Possibly Effective" for Antibiotic-associated diarrhea (Natural Medicines).
  • Also on file: Lactobacillus Acidophilus is rated "Possibly Effective" for Helicobacter pylori, Irritable bowel syndrome (IBS).
  • Also on file: Bacillus Subtilis is rated "Possibly Effective" for Antibiotic-associated diarrhea.

The evidence for these strains is mixed and modest. Lactobacillus acidophilus is possibly effective for irritable bowel syndrome, Helicobacter pylori infection, antibiotic-associated diarrhea, and bacterial vaginosis, but possibly ineffective for atopic disease and rated insufficient evidence for acute respiratory distress syndrome.

Bifidobacterium breve shows possibly ineffective ratings for age-related cognitive decline and sepsis, with insufficient evidence for hay fever, antibiotic-associated diarrhea, and atopic disease. Bacillus subtilis is possibly effective for antibiotic-associated diarrhea but has insufficient evidence for athletic performance, cirrhosis, constipation, eczema, and diabetes.

The evidence we hold doesn't establish that Pro-X10 works for most conditions people might consider it for.

The evidence, ingredient by ingredient Lactobacillus Acidophilus Bifidobacterium Breve Bacillus Subtilis

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 3 of the 3 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 3 of 3.
  • General safety write-ups exist for 3 of 3.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Lactobacillus acidophilus is generally well tolerated in healthy adults and children, though you should check with your doctor before use. Gastrointestinal side effects like bloating, gas, stomach discomfort, and diarrhea can occur but are uncommon.

Rare serious cases of infection—bacteremia, sepsis, and others—have been reported, though these occur mostly in people who are already very ill or immunocompromised. Bifidobacterium breve is generally well tolerated in healthy people but requires caution in those who are very ill or have weak immune systems; bacteremia has occurred rarely in critically ill infants and preterm infants using probiotics.

Bacillus subtilis is generally well tolerated in healthy adults, though safety data are limited and quality can vary by product and strain. A headache was reported in one trial, and rare cases of bacteremia and meningitis linked to a specific Bacillus subspecies have been documented in immunocompromised patients.

Pregnancy safety for these probiotics has not been fully established.

Side effects, ingredient by ingredient Lactobacillus Acidophilus Bifidobacterium Breve Bacillus Subtilis

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 3 of the 3 matched ingredients can interact with medications — Lactobacillus Acidophilus, Bifidobacterium Breve, Bacillus Subtilis.
  • The most serious interaction on file is rated Moderate.
  • For scale: 182 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking Pro-X10, double-check antibiotic drugs with your doctor or pharmacist. Antibiotics are Moderate-severity interactors—taking them at the same time as these probiotics can reduce how well the probiotics work.

Spacing doses by a few hours usually solves this. No other medication interactions are documented for the ingredients we could check.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

Pro-X10 is a multispecies probiotic that may help with antibiotic-associated diarrhea and some digestive concerns, but the evidence is not strong for most conditions. If you take antibiotics, space them apart from this product by a few hours to avoid killing the beneficial organisms.

Anyone who is very ill, immunocompromised, or unsure should talk with their doctor or pharmacist before starting it.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 3 of 7 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Sep 24, 2019.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Pro-X10, straight from the product label.

Brand BioTrust
Barcode (UPC) 096802959417
Net contents 60 Capsule(s)
Market status On market
Date entered into DSLD Sep 24, 2019
DSLD ID 206737
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other
Intended target group(s) Adult (18 - 50 Years), Women (not pregnant or lactating)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Pro-X10 by BioTrust, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container
60
UPC/BARCODE
096802959417
IngredientAmount% DV
Lactobacillus plantarum0 NP--
Lactobacillus acidophilus0 NP--
Bifidobacterium animalis lactis0 NP--
Lactobacillus rhamnosus0 NP--
Bifidobacterium breve0 NP--
Microencapsulated Probiotic Blend0 NP--
DE111 Bacillus subtilis0 NP--
PreforPro7.5 mg--

Other ingredients: Gelatin, Rice Dextrin, Medium Chain Triglyceride, filtered Water

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

Daily GI Health...Times 10 Honest Nutrition for Your Ultimate Body Equivalent to 50 billion CFU per day!

Advanced Probiotic and GI Health Formula Promotes Bowel Regularity & Immune Health Improves Balance of Healthy Bacteria in the Gut Improves GI Function in Hours, Not Weeks

Pro-X10 is a premium probiotic designed to optimize GI health in hours, not days or weeks like the probiotics of yesterday. Pro-X10 uses new ingredients and technologies never before seen in a single product.

Patented Microencapsulation Technology helps protect and enhance the delivery of delicate, living probiotics to the body for optimal gut health.

This product is formulated to deliver the listed potency through the best by date.

Formula

Now with PreforPro

DE111 is Bacillus subtilis, a good bacteria, which promotes healthy microflora, enhances digestion, and optimizes the metabolism of fat. PreforPro is a non-fiber, prebiotic that has been shown to increase the DE111 in Pro-X10 by over 11x within five hours!

DE111 Probiotic

FDA Statement of Identity

Dietary Supplement

Precautions

This product is manufactured in a facility that also processes milk, eggs, wheat, and soy.

Warning: This product is for use by healthy adults over 18 years old.

Consult your physician before use if you are taking any prescription or other medications. Do not use this product if you are pregnant or nursing.

Discontinue use and consult your physician if you experience any adverse reaction to this product. Do not exceed recommended serving size or suggested use.

Keep out of reach of children.

Brand IP Statement(s)

PreforPro and DE111 are registered trademarks of Deerland Enzymes, Inc.

Suggested/Recommended/Usage/Directions

Directions: Take two (2) capsules daily, one (1) capsule with breakfast, and one (1) capsule with dinner.

Storage

Keep refrigerated after opening to maintain maximum potency.

Store in a cool, dry place with lid tightly closed.

See for yourself

Pro-X10 by BioTrust label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Pro-X10 by BioTrust

These are the 7 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Capsule(s) Dosage formCapsule Servings per container60 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Microencapsulated Probiotic Blend

0 NP per serving

DE111 Bacillus subtilis

Interacts with
182 drugs
0 NP per serving

Bacillus subtilis is a spore-forming probiotic bacterium found in soil and some fermented foods, and it is used mainly to support gut health and diges...

DE111 Bacillus subtilis monograph & interactions

PreforPro

7.5 mg per serving

Other (inactive) ingredients: Gelatin, Rice Dextrin, Medium Chain Triglyceride, Filtered Water. These complete the product’s ingredient list but are not active constituents.

Interaction report

Pro-X10 by BioTrust Drug Interactions

Want to check YOUR meds against Pro-X10?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
182Drugs
182 Moderate

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in Pro-X10 with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Lactobacillus acidophilus1 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Lactobacillus acidophilus with antibiotic drugs might decrease the effectiveness of L. acidophilus.
L. acidophilus preparations usually contain live and active organisms. Therefore, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and L. acidophilus preparations by at least two hours.

Likelihood Probable Evidence D

Bifidobacterium breve1 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Bifidobacterium breve with antibiotic drugs might decrease the effectiveness of B. breve.
Since B. breve preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. breve preparations by at least 2 hours.

Likelihood Probable Evidence D

DE111 Bacillus subtilis1 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Bacillus subtilis with antibiotic drugs might decrease the effectiveness of B. subtilis.
Since B. subtilis preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. subtilis preparations by at least 2 hours.

Likelihood Probable Evidence D
The maker

Brand information

Manufacturer and brand details for Pro-X10, from the product label.

BioTrust

See all BioTrust products
Name
BioTrust Nutrition
City
Austin
State
TX
ZipCode
78701
Phone Number
1-800-766-5086
Web Address
BioTrust.com
Pharmacist Counseling Corner

Pro-X10 by BioTrust: Common Questions

Does Pro-X10 by BioTrust interact with any medications?
Yes. Based on its ingredients, Pro-X10 has a known interaction with 182 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Pro-X10 contains 7 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Do I need to stop taking antibiotics while I use Pro-X10?
No—you don't need to stop antibiotics. Instead, separate the timing: take your antibiotic and Pro-X10 a couple of hours apart so the antibiotic doesn't kill the beneficial bacteria in the product. Your doctor or pharmacist can help you figure out the best schedule.
Will Pro-X10 help with my irritable bowel syndrome?
Lactobacillus acidophilus, one ingredient in this product, is rated possibly effective for IBS. That means there's some evidence it may help, but it's not proven for everyone. Talk with your doctor about whether it's worth trying for your situation.
What are the main side effects?
The most common side effects are mild and gastrointestinal—bloating, gas, stomach discomfort, or diarrhea—but they're uncommon. Serious infections from these probiotics are rare and happen mainly in people who are already very ill or have weak immune systems.
Is Pro-X10 safe to use while pregnant or breastfeeding?
The safety data for these probiotics in pregnancy and breastfeeding isn't fully established. There isn't enough information to know either way, so talk with your doctor or pharmacist for personalized advice before taking it during pregnancy or while nursing.
Should I use Pro-X10 if I have a weak immune system?
You should check with your doctor first. While these probiotics are generally well tolerated in healthy people, caution is needed if you're very ill or immunocompromised, since rare infections have been reported in those groups.
Why does this product have so many different probiotic strains?
Different probiotic strains may support your gut in different ways. The variety in Pro-X10—including Lactobacillus and Bifidobacterium species plus Bacillus subtilis—is meant to provide broader support, though the evidence for most conditions is still limited.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Pro-X10 is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Pro-X10 label
Sources

Sources & How We Checked

Pro-X10's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 34 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Lactobacillus Acidophilus 15 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48(10):1127-35 PubMed
  3. Chatterjee S, Kar P, Das T, Ray S, Gangulyt S, Rajendiran C, Mitra M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated
  4. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M,Minakari M, Shavakhi S, Gholamrezaei A. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-c
  5. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 2016;42(4):234-41. PubMed
  6. Badehnoosh B, Karamali M, Zarrati M, et al. The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med. 2018 May;31(9):1128-1136.
  7. Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabete
  8. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  9. Xiao SD, Zhang DZ, Lu H, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60.
  10. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
  11. Ozer M, Goksu SY, Shahverdiani A, Mustafa M. Lactobacillus acidophilus-induced endocarditis and associated splenic abscess. Case Rep Infect Dis 2020;2020:1382709.
  12. Sadrin S, Sennoune S, Gout B, et al. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Dis 2020;52(5):534-540. PubMed
  13. Stoffer JN, Slingsby TJ, Giuliari GP. Lactobacillus acidophilus endophthalmitis after intravitreal bevacizumab injection requiring intraocular lens explantation. Can J Ophthalmol 2022;57(1):e21-e22. PubMed
  14. Cukovic-Cavka S, Likic R, Francetic I, Rustemovic N, Opacic M, Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease. Digestion 2006;73(2-3):107-10.
  15. Hui J, Ren Y, Wang Y, Han Q. Lactobacillus acidophilus endophthalmitis postcataract operation: A case report with a literature review. Ocul Immunol Inflamm 2023.

See these in context on the Lactobacillus Acidophilus monograph →

Bifidobacterium Breve 9 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
  3. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
  4. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156(4):679-81. PubMed
  5. Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65. PubMed
  6. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
  7. Wakabayashi Y, Nakayama S, Yamamoto A, et al. First case of necrotizing fasciitis and bacteremia caused by Bifidobacteriumbreve. Anaerobe 2022;76:102613.
  8. Takeda Y, Ota K, Kondo A, et al. A case of necrotizing fasciitis caused by Bifidobacterium breve. IDCases 2022;31:e01667. PubMed
  9. Suwantarat N, Romagnoli M, Wakefield T, Carroll KC. Ventriculoperitoneal shunt infection caused by Bifidobacterium breve. Anaerobe 2014;28:1-3. PubMed

See these in context on the Bifidobacterium Breve monograph →

Bacillus Subtilis 10 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Lampropoulos PK, Gkentzi D, Tzifas S, Dimitriou G. Neonatal sepsis due to Bacillus subtilis. Cureus 2021;13(9):e17692. PubMed
  3. La Jeon Y, Yang JJ, Kim MJ, et al. Combined Bacillus licheniformis and Bacillus subtilis infection in a patient with oesophageal perforation. J Med Microbiol 2012;61(Pt 12):1766-1769. PubMed
  4. Wallet F, Crunelle V, Roussel-Delvallez M, Fruchart A, Saunier P, Courcol RJ. Bacillus subtilis as a cause of cholangitis in polycystic kidney and liver disease. Am J Gastroenterol 1996;91(7):1477-8.
  5. Velasco E, Martins CA, Tabak D, Bouzas LF. "Bacillus subtilis" infection in a patient submitted to a bone marrow transplantation. Rev Paul Med 1992;110(3):116-7.
  6. Kato A, Yoshifuji A, Komori K, et al. A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma. J Infect Chemother 2022;28(8):1212-1215. PubMed
  7. Freedman KE, Hill JL, Wei Y, et al. Examining the gastrointestinal and immunomodulatory effects of the novel probiotic Bacillus subtilis DE111. Int J Mol Sci 2021;22(5):2453. PubMed
  8. Lefevre M, Racedo SM, Denayrolles M, et al. Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans. Regul Toxicol Pharmacol 2017;83:54-65. PubMed
  9. Hanifi A, Culpepper T, Mai V, et al. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. Benef Microbes 2015;6(1):19-27. PubMed
  10. Tokano M, Tarumoto N, Imai K, et al. A case of bacterial meningitis caused by Bacillus subtilis var. natto. Intern Med. 2022. Epub ahead of print.

See these in context on the Bacillus Subtilis monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring